Lexpos News

Community pharmacy owners are being asked to share their views on preparations for Pharmacy First, ahead of the next full Community Pharmacy England Committee meeting at the end of January. This committee meeting comes at a pivotal moment as the new national Pharmacy First service is due to launch against a backdrop of consolidations and [...]

The post Pharmacy First and the Year Ahead: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

Date issued: 3 January 2024 The Food Standards Agency has issued a company-led medicines recall for: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd Company name: Reckitt Benckiser Healthcare (UK) Ltd Product name: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula Batch number/expiry Product name Batch number Expiry date [...]

The post Company Led Recall: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd appeared first on Community Pharmacy England.

To avoid any delays in payment for electronic prescriptions dispensed in December (Dispense Notification messages submitted by 31 December 2023), pharmacy owners are reminded to submit their corresponding electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) no later than the 5 January 2024. However, with New Year’s Day (1 January 2024) occurring [...]

The post Reminder: Submit your EPS claims by 5 January and FP34Cs by 6 January appeared first on Community Pharmacy England.

Express Dame Priti Patel is among 20 MPs sounding the alarm over pharmacy closures amid “unprecedented pressures”. Around 1,400 pharmacies have closed their doors for good since October 2016, the group warned health minister Andrea Leadsom. The warning stems from a letter coordinated by Community Pharmacy England. Our Chief Executive Janet Morrison said: “Pharmacies are [...]

The post MPs write to Health Minister amid 1,400 pharmacy closures appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Drug alert number: EL (24)A/01 Date issued: 04 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Company name: Quadrant Pharmaceuticals Ltd Product name: Cozaar® [...]

The post Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) appeared first on Community Pharmacy England.